Verastem Oncology to Participate in the B. Riley Securities 4th Annual Oncology Conference
- None.
- None.
To access the live webcast of the fireside chat, please contact your B. Riley Securities sales representative.
Following the event, an archived replay of the fireside chat will be available on the investors section of the Company’s website at www.verastem.com.
About Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition. For more information, please visit www.verastem.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240111104814/en/
Investors:
Ryan Porter
Argot Partners
+1 212-600-1902
ryan.porter@argotpartners.com
Media:
Lisa Buffington
Corporate Communications
+1 781-292-4502
lbuffington@verastem.com
Source: Verastem Oncology
FAQ
What is the event Verastem Oncology (VSTM) will participate in?
Where can I access the live webcast of the fireside chat?
Where will the archived replay of the fireside chat be available?
